1. Carden DL and Granger DN. Pathophysiology of ischaemiareperfusion injury. J Pathol 2000; 190: 255–266.
2. Zhou T, Prather ER, Garrison DE, et al. Interplay between
ROS and antioxidants during ischemia-reperfusion injuries in
cardiac and skeletal muscle. Int J Mol Sci 2018; 19: pii: E417.
3. Tonon J, Cecchini AL, Brunnquell CR, et al. Lung injurydependent oxidative status and chymotrypsin-like activity of
skeletal muscles in hamsters with experimental emphysema.
BMC Musculoskelet Disord 2013; 14: 39.
4. Kahn J and Schemmer P. Control of ischemia-reperfusion
injury in liver transplantation: potentials for increasing the
donor pool. Visc Med 2018; 34: 444–448.
5. Farzamfar S, Hasanpour A, Nazeri N, et al. Extracellular
micro/nanovesicles rescue kidney from ischemiareperfusion injury. J Cell Physiol 2019; 234:
12290–12300.
6. Ismaeel A, Lavado R, Smith RS, et al. Effects of limb revascularization procedures on oxidative stress. J Surg Res 2018;
232: 503–509.
7. Peiris D. A historical perspective on crush syndrome: the clinical application of its pathogenesis, established by the study of
wartime crush injuries. J Clin Pathol 2017; 70: 277–281.
8. Leurcharusmee P, Sawaddiruk P, Punjasawadwong Y, et al.
The possible pathophysiological outcomes and mechanisms
of tourniquet-induced ischemia-reperfusion injury during
total knee arthroplasty. Oxid Med Cell Longev 2018; 2018:
8087598.
9. Hsieh CH, Jeng JC, Jeng SF, et al. MicroRNA profiling in
ischemic injury of the gracilis muscle in rats. BMC Musculoskelet Disord 2010; 11: 123.
10. Noto Y, Shibuya K, Vucic S, et al. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis. Expert Rev Neurother 2016; 16:
1147–1154.
11. Medling BD, Bueno R, Chambers C, et al. The effect of
vitamin E succinate on ischemia reperfusion injury. Hand
(N Y) 2010; 5: 60–64.
12. Bi W, Bi Y, Gao X, et al. Pharmacological protection of
mitochondrial function mitigates acute limb ischemia/
reperfusion injury. Bioorg Med Chem Lett 2016; 26:
4042–4051.
13. Stahl D, Souder N, Probe R, et al. The effects of hypothermia
and L-arginine on skeletal muscle function in ischemiareperfusion injury. J Orthop Trauma 2012; 26: 579–584.
14. Cai J, Jiang Y, Zhang M, et al. Protective effects of
mitochondrion-targeted peptide SS-31 against hind limb
ischemia-reperfusion injury. J Physiol Biochem 2018; 74:
335–343.
15. Hori K, Tsujii M, Iino T, et al. Protective effect of edaravone
for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb. BMC Musculoskelet Disord
2013; 14: 113.
16. Yoshida H, Yanai H, Namiki Y, et al. Neuroprotective effects
of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 2006; 12: 9–20.
17. Group EAIS. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized,
placebo-controlled, double-blind study at multicenters.
Cerebrovasc Dis 2003; 15: 222–229.
18. Yoshino H and Kimura A. Investigation of the therapeutic
effects of edaravone, a free radical scavenger, on amyotrophic
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
Journal of Orthopaedic Surgery 27(3)
lateral sclerosis (phase II study). Amyotroph Lateral Scler
2006; 7: 241–245.
Wang WZ, Fang XH, Stephenson LL, et al. Ischemia/
reperfusion-induced necrosis and apoptosis in the cells isolated from rat skeletal muscle. J Orthop Res 2008; 26:
351–356.
Zong H, Li X, Lin H, et al. Lipoxin A4 pretreatment mitigates
skeletal muscle ischemia-reperfusion injury in rats. Am J
Transl Res 2017; 9: 1139–1150.
Crawford RS, Hashmi FF, Jones JE, et al. A novel model of
acute murine hindlimb ischemia. Am J Physiol Heart Circ
Physiol. 2007; 292: H830–837.
McCormack MC, Kwon E, Eberlin KR, et al. Development of
reproducible histologic injury severity scores: skeletal muscle
reperfusion injury. Surgery 2008; 143: 126–133.
Yagihashi S, Mizukami H, Ogasawara S, et al. The role of the
polyol pathway in acute kidney injury caused by hindlimb
ischaemia in mice. J Pathol 2010; 220: 530–541.
Kemp CM, Parr T, Bardsley RG, et al. Comparison of the
relative expression of caspase isoforms in different porcine
skeletal muscles. Meat Sci 2006; 73: 426–431.
Gillani S, Cao J, Suzuki T, et al. The effect of ischemia
reperfusion injury on skeletal muscle. Injury 2012; 43:
670–675.
Gu JH, Shi J, Dai CL, et al. O-GlcNAcylation reduces
ischemia-reperfusion-induced brain injury. Sci Rep 2017; 7:
10686.
Wang X, Li S, Chen M, et al. Activation of the FXR improves
intestinal cell tolerance to ischemia-reperfusion injury. Shock
2018; 50: 316–323.
Cadenas S. ROS and redox signaling in myocardial ischemiareperfusion injury and cardioprotection. Free Radic Biol Med
2018; 117: 76–89.
29. Prieto I and Monsalve M. ROS homeostasis, a key determinant in liver ischemic-preconditioning. Redox Biol 2017; 12:
1020–1025.
30. Lee GA, Lin TN, Chen CY, et al. Interleukin 15 blockade
protects the brain from cerebral ischemia-reperfusion injury.
Brain Behav Immun 2018; 73: 562–570.
31. Cheng Y, Di S, Fan C, et al. SIRT1 activation by pterostilbene
attenuates the skeletal muscle oxidative stress injury and
mitochondrial dysfunction induced by ischemia reperfusion
injury. Apoptosis 2016; 21: 905–916.
32. Ozyurt H, Ozyurt B, Koca K, et al. Caffeic acid phenethyl
ester (CAPE) protects rat skeletal muscle against ischemiareperfusion-induced oxidative stress. Vascul Pharmacol
2007; 47: 108–112.
33. Zhang N, Komine-Kobayashi M, Tanaka R, et al. Edaravone
reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in
mice brain. Stroke 2005; 36: 2220–2225.
34. Wang HM, Zhang T, Huang JK, et al. Edaravone attenuates
the proinflammatory response in amyloid-beta-treated microglia by inhibiting NLRP3 inflammasome-mediated IL-1beta
secretion. Cell Physiol Biochem 2017; 43: 1113–1125.
35. Fujiwara N, Som AT, Pham LD, et al. A free radical scavenger edaravone suppresses systemic inflammatory responses in
a rat transient focal ischemia model. Neurosci Lett 2016; 633:
7–13.
36. Ikeda K and Iwasaki Y.Edaravone, a free radical scavenger,
delayed symptomatic and pathological progression of motor
neuron disease in the Wobbler mouse. PLoS One 2015; 10:
e0140316.
37. Tsujimoto I, Hikoso S, Yamaguchi O, et al. The antioxidant
edaravone attenuates pressure overload-induced left ventricular hypertrophy. Hypertension 2005; 45: 921–926.
...